Venture Capital

Presto Adds $10 Million To Advance Voice AI Rollout for Enterprise QSR Drive-Thrus

By Amit Chowdhry ● Jan 10, 2026

Presto announced it has added $10 million in new funding to accelerate its AI roadmap and expand deployments of its enterprise voice assistant for quick-service restaurant drive-thrus. The company positioned the raise as growth capital to scale production implementations and deepen its lead in voice AI for large QSR brands.

PureSpectrum Partners With TA Associates To Fund Product Innovation

By Amit Chowdhry ● Jan 10, 2026

PureSpectrum, a market research technology company, said it has entered into a strategic partnership with TA Associates to support continued innovation, platform scaling, and expanded value for customers across the market research ecosystem. Financial terms were not disclosed.

Carna Health: $8 Million Raised To Expand Global Chronic Kidney Disease Screening Platform

By Amit Chowdhry ● Jan 10, 2026

Carna Health announced it has raised $8 million to expand global access to its chronic kidney disease screening and care management technology, following a strategic partnership with Siemens Healthineers to scale preventive kidney care worldwide.

UPenn, BioNTech, And Osage University Partners Launch $50 Million Seed Fund To Back Penn Life Science Startups

By Amit Chowdhry ● Jan 10, 2026

The University of Pennsylvania, BioNTech SE, and Osage University Partners (OUP) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund), a dedicated venture fund focused on early-stage life science companies originating from Penn.

Hadrian Raises Funding At $1.6 Billion Valuation To Scale New U.S. Factories

By Amit Chowdhry ● Jan 10, 2026

Hadrian, a company focused on building advanced U.S. manufacturing capacity for aerospace, defense, and critical infrastructure, announced it has raised expanded capital led by accounts advised by T. Rowe Price Associates. The financing values the company at $1.6 billion, Hadrian said.

Guidepost Growth Equity Closes $521 Million Oversubscribed Fund IV

By Amit Chowdhry ● Jan 10, 2026

Guidepost Growth Equity announced it has closed its fourth fund, Guidepost Growth Equity IV, L.P., with $521 million in total commitments, exceeding the firm’s $500 million fundraising target. The growth equity firm said the vehicle was oversubscribed and drew commitments from both new and existing limited partners.

Vizgen: $48 Million Funding Raised To Scale Spatial Multi-Omics Platform

By Amit Chowdhry ● Jan 10, 2026

Vizgen, a spatial multi-omics company, announced it has closed a $48 million financing led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures, with participation from existing investors.

Enhanced Digital Group: Series A Funding Raised For Expanding Institutional Crypto Derivatives Offering

By Amit Chowdhry ● Jan 10, 2026

Enhanced Digital Group (EDG), a provider of digital asset derivatives solutions, said StoneX Digital, a division of StoneX Group Inc. (Nasdaq: SNEX), led its Series A financing round.

Abbelight: Series B Raised To Expand Super-Resolution Microscopy Adoption

By Amit Chowdhry ● Jan 10, 2026

Abbelight announced it has closed a Series B financing round led by AVANT BIO, as the Paris-based company looks to accelerate product innovation and broaden commercial adoption of its super-resolution microscopy solutions across a wider customer base.

EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline

By Amit Chowdhry ● Jan 10, 2026

EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and Johnson & Johnson, through Johnson & Johnson Innovation – JJDC, with participation from new and existing investors.

32 Biosciences: $40M Series A Launched To Advance GI Mucosal-Immune Therapeutics

By Amit Chowdhry ● Jan 10, 2026

32 Biosciences, a gastrointestinal-focused biotechnology company, announced it will launch a $40 million Series A financing during the 2026 J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026.

BrightHeart: €11 Million Series A Raised To Expand Prenatal Ultrasound AI Platform

By Amit Chowdhry ● Jan 10, 2026

BrightHeart, a Paris-based developer of AI software for prenatal ultrasound, said it has closed an €11 million Series A financing to fund U.S. commercialization, broader European expansion and continued product development for its B-Right AI Platform.

Spangle AI: $15 Million Series A Closed To Build Agentic Infrastructure For Commerce

By Amit Chowdhry ● Jan 10, 2026

Spangle AI, an agentic infrastructure layer for commerce, said it raised a $15 million Series A round led by NewRoad Capital Partners with participation from Madrona, DNX Ventures, Streamlined Ventures, and strategic angel investors, bringing total funding to $21 million.

Luxury Presence: $37 Million Raised To Advance Presence CRM, An AI Relationship Engine For Real Estate Agents

By Amit Chowdhry ● Jan 10, 2026

Luxury Presence, a growth platform used by more than 87,000 residential real estate agents and brands, announced it raised $37 million in new capital to accelerate the development and launch of Presence CRM, which it is positioning as an AI-driven system designed to surface deal opportunities from an agent’s existing network.

Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform

By Amit Chowdhry ● Jan 10, 2026

Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of synthesis. The round was co-led by Elaia, Pfizer Ventures, and Bpifrance as part of its InnoBio investment strategy, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest, and Mission BioCapital.

SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials

By Amit Chowdhry ● Jan 10, 2026

SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic medicine programs toward first-in-human studies.

Engitix: $25 Million Series A Extension Closed To Advance ECM-Targeted Pipeline In Oncology and Fibrosis

By Amit Chowdhry ● Jan 9, 2026

Engitix Therapeutics announced it has closed a $25 million Series A extension financing led by Netherton Investments, a fund investing on behalf of Mike Platt, co-founder and managing director of BlueCrest Capital Management.

Argobio Launches Enodia With €20.7 Million Seed Round To Develop Small Molecules For Protein Degradation

By Amit Chowdhry ● Jan 9, 2026

Argobio Studio announced it has launched Enodia Therapeutics and completed a €20.7 million ($25 million) seed financing to advance a small-molecule platform for targeted protein degradation at the point of protein synthesis, enabled by proteomics and machine learning.

Truelink Capital To Invest In Prime Electric

By Amit Chowdhry ● Jan 9, 2026

Truelink Capital announced it has signed a definitive agreement to make a significant investment in Prime Electric, a Bellevue, Washington-based provider of electrical system repair, installation and maintenance services. Financial terms were not disclosed.

Verana Health: $52 Million Raised And Merger With COTA

By Amit Chowdhry ● Jan 9, 2026

Verana Health announced it has merged with COTA, combining real-world data (RWD) assets and AI-driven curation technology to expand the scale and clinical depth of its offerings for biopharma customers across oncology and other specialties.

Broadview Group Invests In Citadel EHS

By Amit Chowdhry ● Jan 9, 2026

Broadview Group, a St. Louis-based private investment firm, announced it has invested Citadel EHS, an environmental, health, safety, and sustainability (EHS&S) consulting provider.

Lights Out Sports Sells Controlling Stake To A.R.I., Names Zack Ellison Chairman And CEO

By Amit Chowdhry ● Jan 9, 2026

Lights Out Sports said Applied Real Intelligence (A.R.I.) has acquired a controlling majority interest in the combat-sports and media platform, adding an expanded governance role as the company looks to scale across live events, streaming distribution, and brand partnerships.

Warburg Pincus Closes $3 Billion Financial Sector Fund III

By Amit Chowdhry ● Jan 9, 2026

Warburg Pincus announced it has closed Warburg Pincus Financial Sector III (WPFS III) with $3.0 billion of capital commitments, exceeding the fund’s initial $2.5 billion target. The firm said WPFS III launched in 2024 and is its largest financial services-focused fund to date.

MidEuropa Buys Majority Stake In Romanian Business Consult

By Amit Chowdhry ● Jan 9, 2026

MidEuropa, a private equity firm focused on Central Europe, announced it has agreed to acquire a majority stake in Romanian Business Consult (RBC), an IT system integrator serving the retail, banking, and industrial sectors in Romania.

Haveli Investments To Take Majority Stake In Sirion

By Amit Chowdhry ● Jan 9, 2026

Sirion, a contract lifecycle management (CLM) software provider, announced it has signed a definitive agreement for Haveli Investments, an Austin-based technology-focused investment firm, to make a majority investment in the company.

KAHR Bio: $22 Million Raised And Phase 2 Topline Data For DSP107 Combo In MSS Colorectal Cancer

By Amit Chowdhry ● Jan 9, 2026

KAHR Bio announced it posted “strong” topline results from a Phase 2a dose-expansion cohort evaluating its investigational immunotherapy DSP107 in combination with Roche’s atezolizumab (Tecentriq) in late-line metastatic microsatellite stable colorectal cancer (MSS-CRC), a setting where checkpoint inhibitors have historically shown limited benefit.

Pomelo Care: $92 Million Series C At $1.7B Valuation Closed To Expand Beyond Maternity

By Amit Chowdhry ● Jan 9, 2026

Pomelo Care announced it raised $92 million in Series C funding at a $1.7 billion valuation as it moves to broaden its virtual, evidence-based care model beyond maternity into a wider set of women’s and children’s health needs across the lifespan.

Davidson Kempner Closes $1.1+ Billion Income Fund II For Global Asset-Backed Private Credit Strategy

By Amit Chowdhry ● Jan 9, 2026

Davidson Kempner Capital Management announced it has reached a final close for Davidson Kempner Income Fund II, raising aggregate capital commitments to the firm’s global asset-backed private credit strategy, including related separate accounts, to more than $1.1 billion. The firm said the second vintage in the series exceeded its fundraising target.

Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings

By Amit Chowdhry ● Jan 9, 2026

Flywheel, a medical imaging data management and analysis platform, reported record momentum in 2025, launched new products aimed at clinical trial and medical device workflows, and disclosed the close of a $27.5 million equity financing round.

Valinor Enterprises: $54 Million Series A Raised To Expand Defense-Tech Holding Company Model

By Amit Chowdhry ● Jan 9, 2026

Valinor Enterprises, an operational holding company focused on defense and government technology, said it raised $54 million in Series A financing, bringing total capital raised to more than $85 million. The round was led by Friends & Family Capital, a venture firm co-founded by former Palantir CFO Colin Anderson and investor John Fogelsong. Existing backers General Catalyst, Founders Fund, and Red Cell Partners also participated, while new investors included Narya, XYZ Venture Capital, and Fifth Down Capital.